BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zafar H, Raza F, Ma S, Wei Y, Zhang J, Shen Q. Recent progress on nanomedicine-induced ferroptosis for cancer therapy. Biomater Sci 2021;9:5092-115. [PMID: 34160488 DOI: 10.1039/d1bm00721a] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 9.0] [Reference Citation Analysis]
Number Citing Articles
1 Xia Y, Zhang J, Liu G. A prospective strategy leveraging nanomedicine for cancer therapy: Pouring ferroptosis on apoptosis. Nano Today 2023;48:101740. [DOI: 10.1016/j.nantod.2022.101740] [Reference Citation Analysis]
2 Zhao D, Huang X, Tian Y, Zou J, Wang F, Chen X. Fluorescence Imaging-Incorporated Transcriptome Study of Glutathione Depletion-Enhanced Ferroptosis Therapy via Targeting Gold Nanoclusters. ACS Appl Mater Interfaces 2023. [PMID: 36704920 DOI: 10.1021/acsami.2c18289] [Reference Citation Analysis]
3 Yin W, Chang J, Sun J, Zhang T, Zhao Y, Li Y, Dong H. Nanomedicine-mediated ferroptosis targeting strategies for synergistic cancer therapy. J Mater Chem B 2023. [PMID: 36650960 DOI: 10.1039/d2tb02161g] [Reference Citation Analysis]
4 Vangijzegem T, Lecomte V, Ternad I, Van Leuven L, Muller RN, Stanicki D, Laurent S. Superparamagnetic Iron Oxide Nanoparticles (SPION): From Fundamentals to State-of-the-Art Innovative Applications for Cancer Therapy. Pharmaceutics 2023;15. [PMID: 36678868 DOI: 10.3390/pharmaceutics15010236] [Reference Citation Analysis]
5 Liu Y, Hu Y, Jiang Y, Bu J, Gu X. Targeting ferroptosis, the achilles’ heel of breast cancer: A review. Front Pharmacol 2022;13. [DOI: 10.3389/fphar.2022.1036140] [Reference Citation Analysis]
6 Hu H, Xu Q, Mo Z, Hu X, He Q, Zhang Z, Xu Z. New anti-cancer explorations based on metal ions. J Nanobiotechnol 2022;20. [DOI: 10.1186/s12951-022-01661-w] [Reference Citation Analysis]
7 Xin Y, Sun Z, Liu J, Li W, Wang M, Chu Y, Sun Z, Deng G. Nanomaterial-mediated low-temperature photothermal therapy via heat shock protein inhibition. Front Bioeng Biotechnol 2022;10:1027468. [DOI: 10.3389/fbioe.2022.1027468] [Reference Citation Analysis]
8 Qiao C, Wang H, Guan Q, Wei M, Li Z. Ferroptosis-based nano delivery systems targeted therapy for colorectal cancer: insights and future perspectives. Asian Journal of Pharmaceutical Sciences 2022. [DOI: 10.1016/j.ajps.2022.09.002] [Reference Citation Analysis]
9 Cong T, Luo Y, Fu Y, Liu Y, Li Y, Li X. New perspectives on ferroptosis and its role in hepatocellular carcinoma. Chin Med J (Engl) 2022;135:2157-66. [PMID: 36525603 DOI: 10.1097/CM9.0000000000002327] [Reference Citation Analysis]
10 Zhou Y, Guan X, Wang S, Sun H, Ma H, Raza F. N6-Methyladenosine (m6A)-Related lncRNAs Are Potential Signatures for Predicting Prognosis and Immune Response in Lung Squamous Cell Carcinoma. Journal of Oncology 2022;2022:1-13. [DOI: 10.1155/2022/5240611] [Reference Citation Analysis]
11 Wang M, Zhang Q, Li Y, Jin L, Fang Z, Raza F. Metformin Exhibits an Attractive Antineoplastic Effect on Human Endometrial Cancer by Regulating the Hippo Signaling Pathway. Journal of Oncology 2022;2022:1-11. [DOI: 10.1155/2022/5824617] [Reference Citation Analysis]
12 Hu X, Li R, Wu W, Fang K, Zhu Z, Wang Y, Zhou L, Chen M, Dong C, Shi S. A Fe(III)-porphyrin-oxaliplatin(IV) nanoplatform for enhanced ferroptosis and combined therapy. J Control Release 2022;348:660-71. [PMID: 35716884 DOI: 10.1016/j.jconrel.2022.06.019] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
13 Hou S, Hasnat M, Chen Z, Liu Y, Faran Ashraf Baig MM, Liu F, Chen Z. Application Perspectives of Nanomedicine in Cancer Treatment. Front Pharmacol 2022;13:909526. [DOI: 10.3389/fphar.2022.909526] [Reference Citation Analysis]
14 Zhang C, Chen L, Bai Q, Wang L, Li S, Sui N, Yang D, Zhu Z. Nonmetal Graphdiyne Nanozyme-Based Ferroptosis-Apoptosis Strategy for Colon Cancer Therapy. ACS Appl Mater Interfaces 2022;14:27720-32. [PMID: 35674241 DOI: 10.1021/acsami.2c06721] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
15 Xia M, Guo Z, Liu X, Wang Y, Xiao C. A glutathione-responsive sulfur dioxide polymer prodrug selectively induces ferroptosis in gastric cancer therapy. Biomater Sci 2022. [PMID: 35727040 DOI: 10.1039/d2bm00678b] [Reference Citation Analysis]
16 Yan H, Zhai B, Yang F, Chen Z, Zhou Q, Paiva-Santos AC, Yuan Z, Zhou Y. Nanotechnology-Based Diagnostic and Therapeutic Strategies for Neuroblastoma. Front Pharmacol 2022;13:908713. [PMID: 35721107 DOI: 10.3389/fphar.2022.908713] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Zhao Y, Li L, Zhou E, Wang J, Wang Y, Guo L, Zhang X. Lipid-Based Nanocarrier Systems for Drug Delivery: Advances and Applications. Pharmaceutical Fronts 2022;04:e43-e60. [DOI: 10.1055/s-0042-1751036] [Reference Citation Analysis]
18 Rezaei A, Asgari S, Komijani S, Sadat SN, Sabatier JM, Nasrabadi D, Pooshang Bagheri K, Shahbazzadeh D, Akbari Eidgahi MR, De Waard M, Mirzahoseini H. Discovery of Leptulipin, a New Anticancer Protein from theIranian Scorpion, Hemiscorpius lepturus. Molecules 2022;27:2056. [PMID: 35408455 DOI: 10.3390/molecules27072056] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Xiong Y, Su L, Ye F, Zhao S. Inhibition of NADP(H) supply by highly active phosphatase-like ceria nanozymes to boost oxidative stress and ferroptosis. Materials Today Chemistry 2022;23:100672. [DOI: 10.1016/j.mtchem.2021.100672] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Raza F, Zafar H, Khan MW, Ullah A, Khan AU, Baseer A, Fareed R, Sohail M. Recent advances in the targeted delivery of paclitaxel nanomedicine for cancer therapy. Mater Adv . [DOI: 10.1039/d1ma00961c] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
21 Song S, Li W, Liang W, Tian X. The Effects of Chinese Herbal Decoction Combined with Recombinant Human Interferon α2b on MRI Imaging, Tumor Markers, and Immune Function in Patients with Renal Cell Carcinoma. Evid Based Complement Alternat Med 2021;2021:8106974. [PMID: 34733345 DOI: 10.1155/2021/8106974] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
22 Jia D, Gong L, Li Y, Cao S, Zhao W, Hao L, Li S, Pang B, Zhang C, Li S, Zhang W, Chen T, Dong L, Zhou B, Yang D. {BiW 8 O 30 } Exerts Antitumor Effect by Triggering Pyroptosis and Upregulating Reactive Oxygen Species. Angewandte Chemie 2021;133:21619-21626. [DOI: 10.1002/ange.202107265] [Reference Citation Analysis]
23 Fuster MG, Carissimi G, Montalbán MG, Víllora G. Antitumor Activity of Rosmarinic Acid-Loaded Silk Fibroin Nanoparticles on HeLa and MCF-7 Cells. Polymers (Basel) 2021;13:3169. [PMID: 34578069 DOI: 10.3390/polym13183169] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
24 Luengo Morato Y, Ovejero Paredes K, Lozano Chamizo L, Marciello M, Filice M. Recent Advances in Multimodal Molecular Imaging of Cancer Mediated by Hybrid Magnetic Nanoparticles. Polymers (Basel) 2021;13:2989. [PMID: 34503029 DOI: 10.3390/polym13172989] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
25 Schiaffino-Ortega S, Mariotto E, Luque-Navarro PM, Kimatrai-Salvador M, Rios-Marco P, Hurtado-Guerrero R, Marco C, Carrasco-Jimenez MP, Viola G, López-Cara LC. Anticancer and Structure Activity Relationship of Non-Symmetrical Choline Kinase Inhibitors. Pharmaceutics 2021;13:1360. [PMID: 34575436 DOI: 10.3390/pharmaceutics13091360] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]